🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

⚙️ #ejprd #online "International #SummerSchool on #RareDisease Registries and FAIRification of Data" training course - 28 Sept – 2 Oct - Max 30 participants - Registration deadline is July 19 - Course and registration are free of charge For more ℹ️: ejprarediseases.org/index.php/inte…

Next #EpiCARE #webinar: 📅Thursday, 9th July ⏲️5pm CEST Topic: Introduction to Mendelian epilepsies Presenter: Dr Bobby Koeleman, UMC Utrecht International You can register here: attendee.gotowebinar.com/register/65443…

Future improvement of the EU Orphan Medicines Regulation (OMP) could involve more centralised processes for all rare diseases at the EU level. Read Euractiv's interview with EURORDIS-Rare Diseases Europe: bit.ly/3e5YExP

Are you a patient group supporting individuals/families living with a rare or complex #epilepsy? Register for the ePAG Epicare webinar to find out about EpiCARE and how you can get involved as part of their Patient Community. Register here: us02web.zoom.us/webinar/regist…

📢Just added to the list of SCN2A Europe articles! 👉scn2a.eu/articles 📰Sodium channel epilepsies and neurodevelopmental disorders: from disease mechanisms to clinical application doi.org/10.1111/dmcn.1… #SCN2A @wileyneurology Dennis Lal

Great opportunity to know more about #SCN2A and other genetic epilepsies. Join us!

Big congrats to Dr. Perry Spratt! Super proud of my former labmate for his impressive work studying SCN2a, one of the genes commonly associated with autism. Finishing your PhD is hard as hell even outside of a global pandemic. This virtual thesis talk was 🔥 though!

Qué buenas noticias para todos aquellos sufriendo de #Dravet. Seguro que ayudará, poco o mucho, a otras epilepsias genéticas, como #SCN2A.

Well done Stoke Therapeutics! Hopefully you will be reporting similar things for #SCN2A! 💜

📢Just added to the list of SCN2A Europe activities! 👉scn2a.eu/activities 👥Bobby Koeleman: Introduction to Mendelian Epilepsies attendee.gotowebinar.com/recording/8563… #SCN2A EpiCARE @bobbykoeleman

Great to see #SCN2A in the programme! Thank you!

📢Just added to the list of SCN2A Europe articles! 👉scn2a.eu/articles 📰Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence doi.org/10.1016/j.yebe… #SCN2A Epilepsy & Behavior

📢Just added to the list of SCN2A Europe articles! 👉scn2a.eu/articles 📰Overrepresentation of genetic variation in the AnkyrinG interactome is related to a range of neurodevelopmental disorders nature.com/articles/s4143… #SCN2A European Journal of Human Genetics

Quién sabe, igual fue el primer #SCN2A...🤔

Familias #SCN2A, que no se os pase! 👇

Rare Disease Day is being taken to the next level! Thanks to a Chan Zuckerberg Initiative grant announced today, we will amplify the rare disease voice even further. This & a 2nd grant awarded to National Organization for Rare Disorders (NORD) make up $1.3m to support global rare disease community download2.eurordis.org/pressreleases/…

From one fourth to a third of people with autism speak few or no words. Why don't we know more about them? 📖 Read the full story here: bit.ly/3fGfSDw #SPARKstrong #WeAreSPARK

#ejprd – Networking Support Scheme (NSS) #Call aim: encourage #RareDisease n #rarecancers knowledge sharing among health care professionals, researchers, n patients + enable or increase the participation of usually underrepresented EU13 countries ejprarediseases.org/index.php/netw…

Applications are now open for the #EURORDISWinterSchool on Scientific Innovation and Translational Research 👩‍🔬🔬 It will take place on 12-16 April 2021 at the Institut Imagine in Paris. 📑Apply here! openacademy.eurordis.org/winterschool/

We invite you to join Praxis for a virtual SCN2A community discussion, where you can learn more about Praxis, our commitment to the SCN2A community and development programs. To join, click here: praxis.zoom.us/j/96915619319?…] #SCN2A #raredisease